Fuller & Thaler reports 4.67% stake in Integra
Integra LifeSciences Holdings Corp received an amended ownership report from institutional investor Fuller & Thaler Asset Management, Inc. as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Integra LifeSciences Holdings Corp received an amended ownership report from institutional investor Fuller & Thaler Asset Management, Inc. as of 12/31/2025. Fuller & Thaler reports beneficial ownership of 3,636,359.96 shares of Integra common stock, representing 4.67% of the class.
The firm has sole power to vote 3,583,652.96 shares and sole power to dispose of 3,636,359.96 shares, with no shared voting or dispositive power. Fuller & Thaler certifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Integra.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Fuller & Thaler hold in Integra LifeSciences (IART)?
Fuller & Thaler beneficially owns 3,636,359.96 Integra shares, equal to 4.67% of the common stock. The firm reports sole voting power over most of these shares and sole dispositive power over the full amount.
What type of filing did Fuller & Thaler submit for Integra LifeSciences (IART)?
The firm submitted an amended Schedule 13G/A, which is a passive ownership report for large shareholders. It reflects Fuller & Thaler’s position in Integra common stock as of December 31, 2025.
Does Fuller & Thaler seek to influence control of Integra LifeSciences (IART)?
No. Fuller & Thaler certifies the Integra shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
How much voting power does Fuller & Thaler report in Integra LifeSciences (IART)?
Fuller & Thaler reports sole voting power over 3,583,652.96 shares of Integra common stock and no shared voting power. It also holds sole dispositive power over 3,636,359.96 shares.
Why does Fuller & Thaler file as an investment adviser for Integra (IART)?
Fuller & Thaler files as an investment adviser under Rule 13d-1(b). This status reflects its role managing client assets while reporting beneficial ownership of Integra LifeSciences common stock.
Is Fuller & Thaler’s ownership in Integra LifeSciences (IART) above 5%?
No. Fuller & Thaler reports ownership of 4.67% of Integra’s common stock, which is less than 5% of the outstanding class as disclosed in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.